MedTrace Logo

ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest

NCT03119571 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2021-01-27

Study results available
· View outcomes & findings →

Summary

To determine if survival to hospital discharge with good neurological outcome for adults ages 18-75 who are resuscitated from out-of-hospital VT/VF cardiac arrest without clinical signs of a heart attack do better by going straight to the cardiac catheterization laboratory or admitted to the intensive care unit for evaluation. The investigators think a large portion of resuscitated patients presenting with VT/VF have ischemic heart disease which is the cause for the arrest. And prompt access to the cardiac catheterization laboratory to reverse the blocked artery will improve survival with good neurological outcomes.

Conditions

  • Cardiac Arrest Due to Underlying Cardiac Condition
  • Ventricular Fibrillation
  • Cardiopulmonary Arrest With Successful Resuscitation

Interventions

PROCEDURE

Initial CCL admission

Admission to the cardiac catheterization lab to evaluated coronary artery disease and if present fix the culprit lesion/lesions

DIAGNOSTIC_TEST

Initial ICU admission

Evaluate for additional testing and/or procedures

Sponsors & Collaborators

Principal Investigators

  • Demetris Yannopoulos, MD · University of Minnesota

  • Tom Aufderheide, MD · MCW

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-12
Primary Completion
2019-11-26
Completion
2019-11-26
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03119571 on ClinicalTrials.gov